7 completed, 1 unknown. 4 Phase 3, 2 Phase 2, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 3, Unknown 1 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 4 | 1 | Completed 1 |
Follow IgG Deficiency: new trials by email Literature Review of IgG Deficiency trials Research Report on IgG Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France Blood test, chest CT scan - Primary Immunodeficiency, Common Variable Immunodeficiency | Not applicable | Completed | CHU de Reims | 46 | 2022-11-28 | 2025-12-18 |
| IVIG Treatment for Asthmatic Patients With IgG Subclass Deficiency Immune Globulin - Asthma | Phase 3 | Unknown | Ajou University School of Medicine | 30 | 2013-12-01 | 2016-05-02 |
| PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency Prevenar13 - IgG Deficiency | Phase 2 | Completed | Karolinska University Hospital | 20 | 2013-05-01 | 2014-06-16 |
| Treatment of Deficient Subclass or Anti-polysaccharide Antibody Response intravenous immunoglobulins, antibiotics - IgG Deficiency, Infections | Phase 4 | Completed | Prothya Biosolutions | 55 | 2007-11-01 | 2015-04-06 |
| Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 55 | 2005-11-01 | 2012-10-26 |
| Efficacy of IgIv in Patients With IgG Subclass Deficiency and Recurrent Infections IV Gamunex 10% - IgG Deficiency, Infections | Phase 2 | Completed | The Center for Rheumatic Disease, Allergy, & Immunology | 10 | 2004-12-01 | 2007-01-01 |
| Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 89 | 2004-09-01 | 2012-06-06 |
| Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) Immunoglobulins Intravenous (Human) - Agammaglobulinemia, IgG Deficiency | Phase 3 | Completed | CSL Behring | 42 | 2004-09-01 | 2011-02-11 |
Common Variable Immunodeficiency (4) · Agammaglobulinemia (3) · Infections (2) · Asthma (1) · Immunologic Deficiency Syndromes (1) · Primary Immunodeficiency Diseases (1)
Blood Protein Disorders (8) · Dysgammaglobulinemia (8) · Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Immune System Diseases (8) · Immunologic Deficiency Syndromes (7) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Bronchial Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1)
Immunoglobulins, Intravenous (4) · 13-valent pneumococcal vaccine (1) · Anti-Bacterial Agents (1) · Hematologic Tests (1) · Immunoglobulins (1)
CSL Behring (3) · Ajou University School of Medicine (1) · CHU de Reims (1) · Karolinska University Hospital (1) · Prothya Biosolutions (1) · The Center for Rheumatic Disease, Allergy, & Immunology (1)
United States (2) · France (1) · Netherlands (1) · Sweden (1)
E AM Sanders, PhD, MD (1) · J T van Dissel, PhD, MD (1) · Nabih I Abdou, MD, PhD (1) · Peter W Bergman, MD, PhD (1) · T W Kuijpers, PhD, MD (1)
PMID 17479360, PMID 18814020, PMID 19218820, PMID 20217199, PMID 28410816